Return to homepagePandemic Pact

Treatment and prevention of severe lung manifestasions of COVID-19 with Senicapoc (COVIPOC).

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Known Financial Commitments (USD)

    $848,000

  • Funder

    UFM Denmark

  • Principal Investigator

    Professor Ulf Simonsen

  • Research Location

    Denmark

  • Lead Research Institution

    DMSc, Department of Biomedicine Aarhus University, University of Southern Denmark (SDU)

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The project examines whether treatment with the drug senicapoc may lower the need for use of ventilators during the course of the COVID disease. The goal of the project is to examine whether such treatment may hinder the onset of acute respiratory syndrome and hinder lung damages associated with the COVID-19-infection. The impact of the project may be a relief of the health system's resources during COVID-19.